about
Oxidation in rheumatoid arthritis.The challenge of early synovitis: multiple pathways to a common clinical syndromePathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEFamilial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.Expression and function of wingless and frizzled homologs in rheumatoid arthritis.Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis.Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblastsThe identification and characterization of a novel protein, c19orf10, in the synovium.Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines.Oral health in a First Nations and a non-Aboriginal population in Manitoba.Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.Early undifferentiated arthritis.The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patientsAssociation of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization.Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations.Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities.Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.Infection and rheumatoid arthritis: still an open question.Chlamydia pneumoniae present in the human synovium are viable and metabolically active.The influence of uveitis on patients with immune-mediated inflammatory disease.The role of inflammation in the pathophysiology of depression: different treatments and their effects.Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface.Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.If at first you don't succeed: try, try again.Inflammatory Arthritis Prevalence and Health Services Use in the First Nations and Non-First Nations Populations of Alberta, Canada.Neutrophils exhibit distinct phenotypes toward chitosans with different degrees of deacetylation: implications for cartilage repairScaffold-guided subchondral bone repair: implication of neutrophils and alternatively activated arginase-1+ macrophages.Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.Polymorphisms in the sodium-dependent ascorbate transporter gene SLC23A1 are associated with susceptibility to Crohn disease.High degree of correlation between whole blood and PBMC expression levels of miR-155 and miR-146a in healthy controls and rheumatoid arthritis patients.Effect of chitosan particles and dexamethasone on human bone marrow stromal cell osteogenesis and angiogenic factor secretion.The SLC2A14 gene, encoding the novel glucose/dehydroascorbate transporter GLUT14, is associated with inflammatory bowel disease.Characterization of synovial tissue from arthritis patients: a proton magnetic resonance spectroscopic investigation.Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects.Effect of chitosan and coagulation factors on the wound repair phenotype of bioengineered blood clots.
P50
Q21195671-B133787F-CAC8-4C1D-B73E-40D483C83531Q24805007-FF48D6D9-828A-45A6-AB55-55AADD0B1F9EQ27003201-3C59C31A-030D-4F21-8391-49240A0045FEQ34166023-9532D651-0BCA-4EA6-9935-46D4E0E220E5Q35045292-B21F3C1A-20E6-488C-9BC5-BBB9420D50FEQ35081641-786360E8-46B1-4733-AFEE-AF946C2B405BQ35555485-9FEE0B50-B3CF-4B99-B3C2-8770DEC31DF0Q35617710-CE43E232-BA7B-453E-B64B-9A3BDA9DBBE4Q35868991-5AC81E1E-D085-4AD0-81BE-D54AAE1BED05Q36101614-D9E80F50-098D-4926-9E55-727D4E2E187BQ36159823-D8686A10-641E-4F3C-A296-AB10BA81F6C3Q36176344-118A7A31-ED1D-4E1B-A978-E982089EE8FFQ36312900-C87D9574-72E4-47BD-BF5B-DE9A25D11302Q37206890-467CC57C-E739-43E9-966E-660E80F86087Q37217463-4BDC031B-E7CE-4D86-9455-1B390B8A651DQ37289529-6C040C66-68AC-4A93-8D35-D199BE3A823EQ37671218-5DFD38EB-6A9F-4926-9134-D1E367123B9DQ37740847-ED0CA0C3-B2DC-41D8-9863-8A94F0543F48Q37864211-9F47DAB9-4411-49DA-9C7F-3D503D219241Q37870647-8909C62C-2311-426D-A922-0B8F0C69BB41Q37876174-B4C242DC-9CCB-412E-9A5D-E6A247E7B46AQ37951915-CBE5531B-9DF7-43FD-A784-B8C9DBAF7690Q37951919-A4803527-12D8-4973-8240-68F2EF267726Q38628324-9152AE3E-2888-4C10-976B-D3ACEB6BABAFQ38988648-65B1EBB3-6305-4492-A2F3-AA76F649BD8DQ39896479-7D46BA22-1C2E-4067-A757-4CBC810E6565Q40305864-3CBEE499-D689-4755-806E-9B29BCD03CF3Q40384141-F9696140-57A7-4C3C-8B06-27C3E69C8E33Q42560666-008FEFBA-1404-4F14-B838-BA093A14A83AQ43044948-E756A502-26F0-4763-A551-CC7062BDE95DQ43632894-DEB48F33-F87D-415A-A375-A38A201E31A9Q44398367-F212B06F-BC9F-4A67-B4D3-75541E94CFC4Q44442994-2962686A-66B5-417A-883E-F682534D515EQ44555276-BD2A2705-0EC9-4DAC-A872-FF74904234DEQ45154342-4DD69842-7E73-417D-BC3E-8822DA62BCDCQ45264841-5231B905-F0E9-49CF-BE95-6963776EE9BBQ46138287-174B8654-297B-4A23-A553-7BC8E7AD9636Q46640361-C5943BF8-8296-4F51-AD97-4FC0B67701D1Q47103217-E602C018-F546-4F31-8746-7EAD3F964896Q50872226-9ACEC2A7-D7A5-4F21-9A25-B8E569B0EF23
P50
description
researcher ORCID ID = 0000-0002-0796-4422
@en
wetenschapper
@nl
name
Hani El-Gabalawy
@ast
Hani El-Gabalawy
@en
Hani El-Gabalawy
@es
Hani El-Gabalawy
@nl
type
label
Hani El-Gabalawy
@ast
Hani El-Gabalawy
@en
Hani El-Gabalawy
@es
Hani El-Gabalawy
@nl
prefLabel
Hani El-Gabalawy
@ast
Hani El-Gabalawy
@en
Hani El-Gabalawy
@es
Hani El-Gabalawy
@nl
P31
P496
0000-0002-0796-4422